Tango Therapeutics, Inc.·4

Nov 4, 9:25 AM ET

Peters Malte 4

4 · Tango Therapeutics, Inc. · Filed Nov 4, 2025

Insider Transaction Report

Form 4
Period: 2025-11-03
Peters Malte
DirectorPresident & CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-11-03+150,000150,000 total
    Exercise: $8.01Exp: 2035-11-03Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exercisable in 48 substantially equal monthly installments over a period of four years, with the first vesting date on December 3, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4